Global Remicade Biosimilar Market Status and Forecast 2021-2027
Report Code: KNJ943476
Publisher: Date of Publish:
No. of Pages: 163 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Remicade Biosimilar market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Remicade Biosimilar industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies. According to this survey, the global Remicade Biosimilar market is estimated to have reached $ million in 2020, and projected to grow at a CAGR of % to $ million by 2027. Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Remicade Biosimilar Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Remicade Biosimilar market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information. The Global Remicade Biosimilar Market has been exhibited in detail in the following chapters Chapter 1 displays the basic product introduction and market overview. Chapter 2 provides the competition landscape of global Remicade Biosimilar industry. Chapter 3 provides the market analysis by type and by region Chapter 4 provides the market analysis by application and by region Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. Chapter 12 provides the market forecast by type and by application Chapter 13 provides the market forecast by region Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis. Chapter 15 conclusions Segmented by Type 100mg/10ml 500mg/50ml Segmented by Application Blood Disorders Oncology Diseases Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Novartis (Sandoz) Merck Serono (Merck Group) Livzon Pharmaceutical LG Life Sciences Hualan Biological Engineering Hospira Hisun Pharmaceutical Genentech (Roche Group) Fosun Pharmaceutical Celltrion Biogen idec Inc. Biocon Anke Biotechnology
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Remicade Biosimilar Market Status and Forecast (2016-2027) 1.3.2 Global Remicade Biosimilar Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Remicade Biosimilar Supply by Company 2.1 Global Remicade Biosimilar Sales Volume by Company 2.2 Global Remicade Biosimilar Sales Value by Company 2.3 Global Remicade Biosimilar Price by Company 2.4 Remicade Biosimilar Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Remicade Biosimilar Market Status by Type 3.1 Remicade Biosimilar Type Introduction 3.1.1 100mg/10ml 3.1.2 500mg/50ml 3.2 Global Remicade Biosimilar Market by Type 3.2.1 Global Remicade Biosimilar Sales Volume by Type (2016-2021) 3.2.2 Global Remicade Biosimilar Sales Value by Type (2016-2021) 3.2.3 Global Remicade Biosimilar Price by Type (2016-2021) 3.3 North America: by Type 3.4 Europe: by Type 3.5 Asia Pacific: by Type 3.6 Central & South America: by Type 3.7 Middle East & Africa: by Type 4 Global and Regional Remicade Biosimilar Market Status by Application 4.1 Remicade Biosimilar Segment by Application 4.1.1 Blood Disorders 4.1.2 Oncology Diseases 4.2 Global Remicade Biosimilar Market by Application 4.2.1 Global Remicade Biosimilar Sales Volume by Application (2016-2021) 4.2.2 Global Remicade Biosimilar Sales Value by Application (2016-2021) 4.2.3 Global Remicade Biosimilar Price by Application (2016-2021) 4.3 North America: by Application 4.4 Europe: by Application 4.5 Asia Pacific: by Application 4.6 Central & South America: by Application 4.7 Middle East & Africa: by Application 5 Global Remicade Biosimilar Market Status by Region 5.1 Global Remicade Biosimilar Market by Region 5.1.1 Global Remicade Biosimilar Sales Volume by Region 5.1.2 Global Remicade Biosimilar Sales Value by Region 5.2 North America Remicade Biosimilar Market Status 5.3 Europe Remicade Biosimilar Market Status 5.4 Asia Pacific Remicade Biosimilar Market Status 5.5 Central & South America Remicade Biosimilar Market Status 5.6 Middle East & Africa Remicade Biosimilar Market Status 6 North America Remicade Biosimilar Market Status 6.1 North America Remicade Biosimilar Market by Country 6.1.1 North America Remicade Biosimilar Sales Volume by Country (2016-2021) 6.1.2 North America Remicade Biosimilar Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Remicade Biosimilar Market Status 7.1 Europe Remicade Biosimilar Market by Country 7.1.1 Europe Remicade Biosimilar Sales Volume by Country (2016-2021) 7.1.2 Europe Remicade Biosimilar Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Remicade Biosimilar Market Status 8.1 Asia Pacific Remicade Biosimilar Market by Country 8.1.1 Asia Pacific Remicade Biosimilar Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Remicade Biosimilar Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Remicade Biosimilar Market Status 9.1 Central & South America Remicade Biosimilar Market by Country 9.1.1 Central & South America Remicade Biosimilar Sales Volume by Country (2016-2021) 9.1.2 Central & South America Remicade Biosimilar Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Remicade Biosimilar Market Status 10.1 Middle East & Africa Remicade Biosimilar Market by Country 10.1.1 Middle East & Africa Remicade Biosimilar Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Remicade Biosimilar Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Remicade Biosimilar Manufacturing Cost Analysis 11.5 Remicade Biosimilar Sales Channel and Distributors Analysis 11.5.1 Remicade Biosimilar Sales Channel 11.5.2 Remicade Biosimilar Distributors 11.6 Remicade Biosimilar Downstream Major Buyers 12 Global Remicade Biosimilar Market Forecast by Type and by Application 12.1 Global Remicade Biosimilar Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Remicade Biosimilar Forecast by Type 12.2.1 Global Remicade Biosimilar Sales Volume Forecast by Type 12.2.2 Global Remicade Biosimilar Sales Value Forecast by Type 12.2.3 Global Remicade Biosimilar Price Forecast by Type 12.3 Global Remicade Biosimilar Forecast by Application 12.3.1 Global Remicade Biosimilar Sales Volume Forecast by Application 12.3.2 Global Remicade Biosimilar Sales Value Forecast by Application 12.3.3 Global Remicade Biosimilar Price Forecast by Application 13 Global Remicade Biosimilar Market Forecast by Region/Country 13.1 Global Remicade Biosimilar Market Forecast by Region (2022-2027) 13.1.1 Global Remicade Biosimilar Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Remicade Biosimilar Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Walvax Biotechnology 14.1.1 Company Information 14.1.2 Remicade Biosimilar Product Introduction 14.1.3 Walvax Biotechnology Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Synthon Pharmaceuticals 14.2.1 Company Information 14.2.2 Remicade Biosimilar Product Introduction 14.2.3 Synthon Pharmaceuticals Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Novartis (Sandoz) 14.3.1 Company Information 14.3.2 Remicade Biosimilar Product Introduction 14.3.3 Novartis (Sandoz) Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Merck Serono (Merck Group) 14.4.1 Company Information 14.4.2 Remicade Biosimilar Product Introduction 14.4.3 Merck Serono (Merck Group) Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Livzon Pharmaceutical 14.5.1 Company Information 14.5.2 Remicade Biosimilar Product Introduction 14.5.3 Livzon Pharmaceutical Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 LG Life Sciences 14.6.1 Company Information 14.6.2 Remicade Biosimilar Product Introduction 14.6.3 LG Life Sciences Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 Hualan Biological Engineering 14.7.1 Company Information 14.7.2 Remicade Biosimilar Product Introduction 14.7.3 Hualan Biological Engineering Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Hospira 14.8.1 Company Information 14.8.2 Remicade Biosimilar Product Introduction 14.8.3 Hospira Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Hisun Pharmaceutical 14.9.1 Company Information 14.9.2 Remicade Biosimilar Product Introduction 14.9.3 Hisun Pharmaceutical Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Genentech (Roche Group) 14.10.1 Company Information 14.10.2 Remicade Biosimilar Product Introduction 14.10.3 Genentech (Roche Group) Remicade Biosimilar Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Fosun Pharmaceutical 14.12 Celltrion 14.13 Biogen idec Inc. 14.14 Biocon 14.15 Anke Biotechnology 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com